Interest of the Virtual Reality Headset in the Management of Perioperative Stress in Patients Candidates for Total Thyroidectomy
NCT ID: NCT04481893
Last Updated: 2025-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2020-11-18
2025-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Video-assisted Thyroid Surgery and Hypnosis in Thyroid Surgery
NCT01752283
Effect of Cervical Block on Recurrent Laryngeal Nerve Monitoring During Thyroid Surgery
NCT04585126
Comparative Study Between Transcutaneous Ultrasonography and Direct Laryngoscopy for Assessment of Vocal Cord Mobility at the End of Thyroidectomy Operation
NCT06951295
The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach
NCT04842942
Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery
NCT04873531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
using a virtual reality headset
Use of a virtual reality headset
The intervention will consist of 2 sessions of 30 minutes each, based on the use of a virtual reality headset with the AQUA® application.
* The 1st session will take place on the day of the surgical intervention, upon arrival in hospital, after reception in the room.
* The 2nd session will take place the same day, post-operatively, once the awakening is satisfactory (within 3 to 6 hours after the intervention)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of a virtual reality headset
The intervention will consist of 2 sessions of 30 minutes each, based on the use of a virtual reality headset with the AQUA® application.
* The 1st session will take place on the day of the surgical intervention, upon arrival in hospital, after reception in the room.
* The 2nd session will take place the same day, post-operatively, once the awakening is satisfactory (within 3 to 6 hours after the intervention)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Man or woman
* Patient candidate for a total thyroidectomy, or a thyroid totalization
* Preoperative Euthyroidism
* Can justify outpatient care: score of the American Society of Anesthesiology (ASA) 1, 2 or 3 stable; accompanied for return at home; can be watched by a loved one the night after returning home; reachable by telephone; living within an hour of transportation from a hospital and having a good level of understanding.
* No history of parathyroid or recurrent pathology
* Signature of informed consent before any specific procedure related to the study
* Subject affiliated with a health security system
Exclusion Criteria
* Patient with uncontrolled infectious pathology
* Pregnant or breastfeeding woman or lack of contraception during genital activity
* Patient with illnesses or conditions that hinder their ability to understand follow and / or comply with study procedures
* Patient with personality disorders and / or psychiatric pathology
* Patient deprived of liberty or placed under the authority of a guardian
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre François Baclesse
Caen, , France
CHU CAEN
Caen, , France
Clinique Mathilde
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00182-37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.